Testing effectiveness (Phase 2)Study completedNCT04677660What this trial is testingTAK-919 in Healthy Japanese Adults (COVID-19)Who this might be right forCoronavirus Disease (COVID-19) Takeda 200
Early research (Phase 1)Not Yet RecruitingNCT07645235What this trial is testingEvaluate Gepotidacin Exposure in Breast Milk of Healthy Lactating WomenWho this might be right forUrinary Tract Infections GlaxoSmithKline 8
Early research (Phase 1)Study completedNCT06013150What this trial is testingStudy of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants.Who this might be right forAnaphylactic Reaction De Motu Cordis 24
Not applicableStudy completedNCT06908395What this trial is testingImpact Of Everyday Light Exposure Patterns On HealthWho this might be right forHealthy Male and Female SubjectsHealthy Elderly RWTH Aachen University 62
Not applicableLooking for participantsNCT07535619What this trial is testingThe Voided Urinary, Perineal, and Faecal Microbiota Among Children and Adolescents - the PpUF-study.Who this might be right forUrinary IncontinenceDaytime WettingUrination Disorders+5 more Aalborg University Hospital 110
Early research (Phase 1)Study completedNCT02341599What this trial is testingStudy of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001)Who this might be right forHealthy VolunteersRenal Impairment Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 40
Early research (Phase 1)Study completedNCT01451775What this trial is testingInvestigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.Who this might be right forHealthy Boehringer Ingelheim 18
Early research (Phase 1)Study completedNCT04926701What this trial is testingA First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy SubjectsWho this might be right forCystic Fibrosis Enterprise Therapeutics Ltd 98
Not applicableLooking for participantsNCT07248371What this trial is testingValidating Integrative Multi-omics Approaches in Metabolic Syndrome-related DiseasesWho this might be right forMetabolic Syndrome (MetS)Obesity & OverweightCardiovascular Diseases (CVD)+3 more Chang Gung Memorial Hospital 6,266
Not applicableEnded earlyNCT00026702What this trial is testingSearch for New Methods to Detect Acute Renal FailureWho this might be right forKidney DiseaseKidney FailureKidney Failure, Chronic+2 more National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 226
Early research (Phase 1)Study completedNCT02547402What this trial is testingThe PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy MalesWho this might be right forAcute Kidney Injury Complexa, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT05575492What this trial is testingMRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of AgeWho this might be right forCytomegalovirus ModernaTX, Inc. 873
Not applicableStudy completedNCT06104670What this trial is testingThe Effect of Synaquell™ in Contact Sport AthletesWho this might be right forHealthy Mayo Clinic 25
Early research (Phase 1)Study completedNCT05124717What this trial is testingFed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female VolunteersWho this might be right forPharmacokinetics Joint Stock Company "Farmak" 28
Not applicableStudy completedNCT05890690What this trial is testingPlasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia SyndromeWho this might be right forArginine Vasopressin DeficiencyPrimary Polydipsia University Hospital, Basel, Switzerland 48
Early research (Phase 1)Study completedNCT01266980What this trial is testingAssess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment.Who this might be right forPulmonary Disease, Chronic Obstructive GlaxoSmithKline 18
Early research (Phase 1)Study completedNCT00967174What this trial is testingCumulative Skin Irritation Potential of a New 25 mg Nicotine PatchWho this might be right forSmoking Cessation McNeil AB 42
Early research (Phase 1)Study completedNCT02273518What this trial is testingStudy to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female VolunteersWho this might be right forHealthy Boehringer Ingelheim 18
Early research (Phase 1)Study completedNCT05404542What this trial is testingTo Evaluate Pharmacokinetics (PK) and Safety of Tavapadon in Participants With Severe Renal Impairment Compared to Participants With Normal Renal FunctionWho this might be right forRenal Impairment Cerevel Therapeutics, LLC 14
Testing effectiveness (Phase 2)Study completedNCT02706886What this trial is testingStudy of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1Who this might be right forPrimary Hyperoxaluria Type 1 (PH1) Alnylam Pharmaceuticals 52